Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Oncology_Drug_Advisory_Committee> ?p ?o. }
Showing items 1 to 29 of
29
with 100 items per page.
- Oncology_Drug_Advisory_Committee abstract "The Oncologic Drugs Advisory Committee (ODAC) receives requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration (FDA). The committee, consisting of members from academic and clinical oncology biostatistics, the general public, and the pharmaceutical industry, makes non-binding recommendations to both the CDER and CBER divisions of the FDA about the advisability of approving new medications to treat cancer.".
- Oncology_Drug_Advisory_Committee wikiPageExternalLink default.htm.
- Oncology_Drug_Advisory_Committee wikiPageExternalLink default.htm.
- Oncology_Drug_Advisory_Committee wikiPageID "9889337".
- Oncology_Drug_Advisory_Committee wikiPageRevisionID "522670631".
- Oncology_Drug_Advisory_Committee hasPhotoCollection Oncology_Drug_Advisory_Committee.
- Oncology_Drug_Advisory_Committee subject Category:Food_and_Drug_Administration.
- Oncology_Drug_Advisory_Committee subject Category:National_agencies_for_drug_regulation.
- Oncology_Drug_Advisory_Committee subject Category:Pharmacy_in_the_United_States.
- Oncology_Drug_Advisory_Committee subject Category:Regulators_of_biotechnology_products.
- Oncology_Drug_Advisory_Committee type Abstraction100002137.
- Oncology_Drug_Advisory_Committee type AdministrativeUnit108077292.
- Oncology_Drug_Advisory_Committee type Agency108337324.
- Oncology_Drug_Advisory_Committee type Group100031264.
- Oncology_Drug_Advisory_Committee type NationalAgenciesForDrugRegulation.
- Oncology_Drug_Advisory_Committee type Organization108008335.
- Oncology_Drug_Advisory_Committee type SocialGroup107950920.
- Oncology_Drug_Advisory_Committee type Unit108189659.
- Oncology_Drug_Advisory_Committee type YagoLegalActor.
- Oncology_Drug_Advisory_Committee type YagoLegalActorGeo.
- Oncology_Drug_Advisory_Committee type YagoPermanentlyLocatedEntity.
- Oncology_Drug_Advisory_Committee comment "The Oncologic Drugs Advisory Committee (ODAC) receives requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration (FDA). The committee, consisting of members from academic and clinical oncology biostatistics, the general public, and the pharmaceutical industry, makes non-binding recommendations to both the CDER and CBER divisions of the FDA about the advisability of approving new medications to treat cancer.".
- Oncology_Drug_Advisory_Committee label "Oncology Drug Advisory Committee".
- Oncology_Drug_Advisory_Committee sameAs m.02pv_g6.
- Oncology_Drug_Advisory_Committee sameAs Q7092095.
- Oncology_Drug_Advisory_Committee sameAs Q7092095.
- Oncology_Drug_Advisory_Committee sameAs Oncology_Drug_Advisory_Committee.
- Oncology_Drug_Advisory_Committee wasDerivedFrom Oncology_Drug_Advisory_Committee?oldid=522670631.
- Oncology_Drug_Advisory_Committee isPrimaryTopicOf Oncology_Drug_Advisory_Committee.